# Sumitomo Pharma Co., Ltd. clinical trials: 25 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 25 trials with Sumitomo Pharma Co., Ltd. as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Sumitomo Pharma Co., Ltd.: 25 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/sumitomo-pharma-co-ltd

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 25
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 25, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| June 14, 2024 | NCT06460064 | First-in-human Study to Assess the Safety, Tolerability and Immunogenicity of the Adjuvanted Universal Influenza Vaccine fH1/DSP-0546LP | Sumitomo Pharma Co., Ltd. | Phase 1 | Completed | Influenza | 144 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06460064) |
| June 28, 2022 | NCT05435729 | A Pharmacodynamics and Safety Study of DSP-9632P in Patients With Levodopa-Induced Dyskinesia in Parkinson's Disease | Sumitomo Pharma Co., Ltd. | Phase 1 | Completed | Levodopa-induced Dyskinesia, Parkinson's Disease | 7 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05435729) |
| May 3, 2022 | NCT05359081 | A Clinical Trial to Evaluate the Long-term Safety and Tolerability of SEP-363856 in Patients With Schizophrenia in Japan | Sumitomo Pharma Co., Ltd. | Phase 3 | Terminated | Schizophrenia | 68 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05359081) |
| April 1, 2021 | NCT04825860 | A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia, Followed by an... | Sumitomo Pharma Co., Ltd. | Phase 2/3 | Terminated | Schizophrenia | 83 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04825860) |
| March 30, 2020 | NCT04325737 | Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Japanese Male and Female Subjects With Schizophrenia | Sumitomo Pharma Co., Ltd. | Phase 1 | Completed | Schizophrenia | 13 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04325737) |
| June 20, 2018 | NCT03563560 | A Study of DSP-2033 (Alvocidib) in Patients With Acute Myeloid Leukemia | Sumitomo Pharma Co., Ltd. | Phase 1 | Completed | Acute Myeloid Leukemia | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03563560) |
| December 12, 2017 | NCT03370640 | Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Japanese Male and Female Subjects With Schizophrenia in 2... | Sumitomo Pharma Co., Ltd. | Phase 1 | Completed | Schizophrenia | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03370640) |
| April 26, 2016 | NCT02750891 | A Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas | Sumitomo Pharma Co., Ltd. | Phase 1/2 | Completed | Glioblastoma, Diffuse Intrinsic Pontine Glioma | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02750891) |
| December 30, 2015 | NCT02641873 | A Study of BBI608 Administrated With FOLFIRI + Bevacizumab in Adult Patients With Metastatic Colorectal Cancer | Sumitomo Pharma Co., Ltd. | Phase 1 | Completed | Metastatic Colorectal Cancer | 4 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02641873) |
| May 6, 2015 | NCT02436252 | Study of DSP-7888 in Patients With Myelodysplastic Syndrome | Sumitomo Pharma Co., Ltd. | Phase 1/2 | Completed | Myelodysplastic Syndrome | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02436252) |
| February 9, 2015 | NCT02358395 | A Study of BBI608 Administrated With Sorafenib in Adult Patients With Advanced Hepatocellular Carcinoma | Sumitomo Pharma Co., Ltd. | Phase 1 | Completed | Hepatocellular Carcinoma | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02358395) |
| February 3, 2015 | NCT02354898 | A Study of BBI503 in Advanced Solid Tumors, or BBI503/ Sorafenib in Advanced Hepatocellular Carcinoma | Sumitomo Pharma Co., Ltd. | Phase 1 | Completed | Advanced Solid Tumors, Hepatocellular Carcinoma | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02354898) |
| January 28, 2015 | NCT02347917 | A Study of BBI608 in Combination With Pemetrexed and Cisplatin in Adult Patients With Malignant Pleural Mesothelioma | Sumitomo Pharma Co., Ltd. | Phase 1/2 | Completed | Malignant Pleural Mesothelioma, Non-Small Cell Lung Cancer | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02347917) |
| January 12, 2015 | NCT02335658 | Long-term Study of DSP-5423P in Patients With Schizophrenia | Sumitomo Pharma Co., Ltd. | Phase 3 | Completed | Schizophrenia | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02335658) |
| November 10, 2014 | NCT02287584 | Confirmatory Study of DSP-5423P in Patients With Schizophrenia | Sumitomo Pharma Co., Ltd. | Phase 3 | Completed | Schizophrenia | 580 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02287584) |
| November 18, 2013 | NCT01986114 | A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder. | Sumitomo Pharma Co., Ltd. | Phase 3 | Completed | Bipolar I Disorder | 495 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01986114) |
| November 18, 2013 | NCT01986101 | A Phase III Study of SM-13496 in Patients With Bipolar I Depression. | Sumitomo Pharma Co., Ltd. | Phase 3 | Completed | Bipolar Depression | 525 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01986101) |
| June 8, 2012 | NCT01614912 | Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia | Sumitomo Pharma Co., Ltd. | Phase 3 | Completed | Schizophrenia | 284 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01614912) |
| June 8, 2012 | NCT01614899 | A Phase III Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia | Sumitomo Pharma Co., Ltd. | Phase 3 | Completed | Schizophrenia | 457 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01614899) |
| September 22, 2010 | NCT01207011 | Amrubicin (AMR) Trial in Patients With Non-small Cell Lung Cancer | Sumitomo Pharma Co., Ltd. | Phase 3 | Completed | Lung Cancer | 202 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01207011) |
| May 17, 2010 | NCT01124396 | DSP-3025 A Phase 1 Study of Healthy Male Volunteers | Sumitomo Pharma Co., Ltd. | Observational | Completed | Healthy | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01124396) |
| June 22, 2009 | NCT00925678 | DSP-3025 Study of Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of Season | Sumitomo Pharma Co., Ltd. | Phase 1 | Completed | Allergic Rhinitis, Healthy Volunteer | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00925678) |
| July 8, 2008 | NCT00711269 | Study of SM-13496 (Lurasidone HCl) in Patients With Schizophrenia | Sumitomo Pharma Co., Ltd. | Phase 3 | Completed | Schizophrenia | 460 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00711269) |
| February 3, 2006 | NCT00286169 | Amrubicin Study for Elderly Patients With Extensive-disease Small-cell Lung Cancer (ED-SCLC) | Sumitomo Pharma Co., Ltd. | Phase 3 | Terminated | Small-cell Lung Cancer | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00286169) |
| January 11, 2005 | NCT00101426 | Safety and Efficacy of AS-3201 in the Treatment of Diabetic Sensorimotor Polyneuropathy | Sumitomo Pharma Co., Ltd. | Phase 3 | Completed | Diabetic Neuropathy | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00101426) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 9 |
| Phase 1/2 | 3 |
| Phase 2/3 | 1 |
| Phase 3 | 11 |
| Observational | 1 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 22 |
| Terminated | 3 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Schizophrenia | 9 |
| Carcinoma, Hepatocellular | 2 |
| Diabetic Neuropathies | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Parkinson Disease | 1 |
| Influenza, Human | 1 |
| Colorectal Neoplasms | 1 |
| Glioblastoma | 1 |
| Diffuse Intrinsic Pontine Glioma | 1 |
| Glioma | 1 |
| Lung Neoplasms | 1 |
| Rhinitis, Allergic | 1 |
| Small Cell Lung Carcinoma | 1 |
| Mesothelioma, Malignant | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Bipolar Disorder | 1 |
| Myelodysplastic Syndromes | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Court reporters in the United States](https://specstream.ai/data/businesses/court-reporters/united-states)
- [Countertop installers in the United States](https://specstream.ai/data/businesses/countertop-installers/united-states)
- [Cosmetic surgery practices in the United States](https://specstream.ai/data/businesses/cosmetic-surgery-practices/united-states)
- [Cosmetic dentistry practices in the United States](https://specstream.ai/data/businesses/cosmetic-dentistry-practices/united-states)
- [Cooking schools in the United States](https://specstream.ai/data/businesses/cooking-schools/united-states)
- [Contract law firms in the United States](https://specstream.ai/data/businesses/contract-law-firms/united-states)
